DIA423.63+7.30 1.75%
SPX5,918.17+115.35 1.99%
IXIC19,171.52+434.31 2.32%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·05/09/2025 17:06:39
Listen to the news

Gainers

  • Regencell Bioscience (NASDAQ:RGC) stock moved upwards by 43.9% to $305.0 during Friday's regular session. The company's market cap stands at $3.9 billion.
  • Phathom Pharmaceuticals (NASDAQ:PHAT) shares rose 39.29% to $3.19. The company's market cap stands at $222.1 million.
  • SCWorx (NASDAQ:WORX) shares rose 38.75% to $0.76. The market value of their outstanding shares is at $1.7 million.
  • Definitive Healthcare (NASDAQ:DH) shares increased by 32.74% to $3.73. The market value of their outstanding shares is at $402.7 million. The company's, Q1 earnings came out yesterday.
  • Corvus Pharma (NASDAQ:CRVS) shares increased by 29.85% to $4.35. The market value of their outstanding shares is at $296.5 million. The company's, Q1 earnings came out yesterday.
  • LogicMark (NASDAQ:LGMK) shares rose 28.37% to $0.01.

Losers

  • NuCana (NASDAQ:NCNA) stock fell 53.8% to $0.05 during Friday's regular session.
  • Iovance Biotherapeutics (NASDAQ:IOVA) stock declined by 43.85% to $1.78. The company's market cap stands at $594.4 million. As per the press release, Q1 earnings came out yesterday.
  • Organogenesis Holdings (NASDAQ:ORGO) stock decreased by 43.36% to $3.02. The market value of their outstanding shares is at $383.7 million. As per the press release, Q1 earnings came out yesterday.
  • ENDRA Life Sciences (NASDAQ:NDRA) stock decreased by 43.09% to $3.5. The company's market cap stands at $1.8 million.
  • CVRx (NASDAQ:CVRX) shares decreased by 37.46% to $4.87. The company's market cap stands at $126.6 million. The company's, Q1 earnings came out yesterday.
  • Polyrizon (NASDAQ:PLRZ) stock decreased by 35.85% to $0.38. The market value of their outstanding shares is at $2.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.